Zobrazeno 1 - 10
of 44
pro vyhledávání: '"BASAK YALICI ARMAGAN"'
Autor:
Ecem Bostan, Adam Jarbou, Aysen Karaduman, Duygu Gulseren, Neslihan Akdogan, Basak Yalici-armagan
Publikováno v:
Dermatology Practical & Conceptual, Vol 12, Iss 4 (2022)
Introduction: Hidradenitis suppurativa (HS) is a chronic, disabling skin disorder which is characterized by recurrent attacks of nodule, abscess, sinus tract formation which eventually leads to significant scarring. Oral/topical antibiotics, oral ret
Externí odkaz:
https://doaj.org/article/ad2c360b40da4e19ab49511e86e50ad1
Autor:
Ecem Bostan, Ozay Gokoz, Sibel Dogan, Duygu Gulseren, Neslihan Akdogan, Basak Yalici-armagan, Sibel Ersoy-Evans, Gonca Elcin, Aysen Karaduman
Publikováno v:
Dermatology Practical & Conceptual, Vol 12, Iss 4 (2022)
Introduction: Erythroderma is a life-threatening dermatologic emergency which is characterized by diffuse erythema and exfoliation affecting more than 90% of the body surface area. Most common cutaneous diseases associated with erythroderma are syste
Externí odkaz:
https://doaj.org/article/f9351b26257a49008d7be327f6eab532
Publikováno v:
Dermatology Practical & Conceptual, Vol 12, Iss 3 (2022)
Externí odkaz:
https://doaj.org/article/2eac609a946d475d918b754ed3f73629
Publikováno v:
Dermatology Practical & Conceptual, Vol 12, Iss 3 (2022)
Background: In the new circumstances of Coronavirus disease 2019 pandemic, teledermatology and teledermoscopy have become more important in daily practice for departments which visuality is at the forefront as dermatology and plastic and reconstructi
Externí odkaz:
https://doaj.org/article/a4fbbcc447d34985813acc9eda76a9a0
Publikováno v:
Dermatology Practical & Conceptual, Vol 12, Iss 2 (2022)
Externí odkaz:
https://doaj.org/article/fb7ff5ce3818407b99e84e02b6498448
Autor:
Buket Acar, Abdullah C. Akman, Ali Emre Aksu, Fatih Aktoz, Mesut Altan, Burcu Ancın, Yonca Ozkan Arat, Ahmet Aydin, Demir Bajin, Ozan Bitik, Etkin Boynuyogun, Mustafa Cankurtaran, Ugur Canpolat, Halil Ibrahim Canter, Serdar Ceylan, Emine Ciftci, Eray Copcu, Sehend Debbağ, Ilayda Demirdis, Cenk Demirdover, H. Burcu Demirdover, Ayse Dikmeer, Hilmi Anıl Dinçer, Riza Dogan, Gonca Elcin, Özlem Erden Aki, Cagil Meric Erenoglu, Mert Eşme, Ahmet Gudeloglu, Huseyin Guner, Hilal Gunes, Majid Ismayilzada, Güven Ozan Kaplan, Murat Kara, Yiğitcan Karanfil, Hulya Karatas, Oğuzhan Katar, Bilgen Katipoglu Erenoglu, Ersoy Konaş, Feza Korkusuz, Ahmet Kucukguven, Arda Kucukguven, Fethiye Damla Menkü Özdemir, Ramazan Mercan, Melike Mut, Seda Hanife Oguz, Arzu Okyar Baş, Fatma Oz Bagci, Fatma Figen Özgür, Sule Öztan, Onur Saydam, Yusuf Ziya Şener, Zekeriya Tosun, Fulya Turan, Galip Gencay Üstün, Serkan Uysal, Hakan Uzun, İbrahim Vargel, Basak Yalici-Armagan, Görkem Yavaş, Muge Yemisci, Bulent Okan Yildiz, Süleyman Yıldızdal, Mahmut Muhsin Yilmaz, Kaya Yorgancı
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d0280e5545c9cc3d72e354673d0b2ef8
https://doi.org/10.1016/b978-0-323-98804-9.09989-8
https://doi.org/10.1016/b978-0-323-98804-9.09989-8
Publikováno v:
Acta Medica.
Verrucous venocapillary malformation, formerly known as verrucous hemangioma, presents itself as single or multiple, well-demarcated, erythematous plaques that eventually acquire hyperkeratinization, oozing, bleeding and become thicker and darker ove
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::74f47e7fb49ce0bad5dc2137b0a7d8b6
https://doi.org/10.32552/2022.actamedica.787
https://doi.org/10.32552/2022.actamedica.787
Publikováno v:
Archives of Rheumatology. 37:479-481
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2420ebf47118731e554de127eced88af
https://doi.org/10.46497/archrheumatol.2022.9210
https://doi.org/10.46497/archrheumatol.2022.9210
Autor:
Gonca Elçin, Basak Yalici-Armagan, Ayşen Karaduman, Sibel Ersoy-Evans, Fethi Zaid, Neslihan Akdogan, Sibel Dogan, Ecem Bostan, Duygu Gülseren
Publikováno v:
Journal of Cosmetic Dermatology
Introduction Chronic spontaneous urticaria (CSU) is defined as recurrent attacks of urticaria present for more than six weeks. The monoclonal anti-immunoglobulin E antibody, omalizumab, was approved for the treatment of CSU in patients who remain ref
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af793de99ce63f2cf092e8306e9236ec
http://europepmc.org/articles/PMC8661558
http://europepmc.org/articles/PMC8661558